MySalvia Therapy
Chronic Migraine
Key Facts
About Salvia BioElectronics
Salvia BioElectronics is a private, clinical-stage MedTech company developing an implantable bioelectronic neuromodulation system for chronic migraine and cluster headache. The company's core technology, MySalvia Therapy, consists of ultra-thin implants targeting key nerves and a wearable device for patient activation, aiming to provide a drug-free treatment option. Backed by a recent $60M Series B financing, Salvia is advancing clinical studies from its base at the High Tech Campus in Eindhoven. The company operates pre-revenue, with its therapy not yet approved for commercial use.
View full company profileAbout Salvia BioElectronics
Salvia BioElectronics is a private, clinical-stage MedTech company developing an implantable bioelectronic neuromodulation system for chronic migraine and cluster headache. The company's core technology, MySalvia Therapy, consists of ultra-thin implants targeting key nerves and a wearable device for patient activation, aiming to provide a drug-free treatment option. Backed by a recent $60M Series B financing, Salvia is advancing clinical studies from its base at the High Tech Campus in Eindhoven. The company operates pre-revenue, with its therapy not yet approved for commercial use.
View full company profileTherapeutic Areas
Other Chronic Migraine Drugs
| Drug | Company | Phase |
|---|---|---|
| Implantable Migraine Therapy System | ShiraTronics | Pivotal Trial |
| ABP-450 | AEON Biopharma | Preclinical/Planned |